Clinical and Economic Outcomes in Patients With Alpha-1 Antitrypsin Deficiency in a US Medicare Advantage Population

Clinical and Economic Outcomes in Patients With Alpha-1 Antitrypsin Deficiency in a US Medicare Advantage Population

**Background:** Alpha-1 antitrypsin deficiency (AATD) testing rates and associated clinical and economic outcomes data in the US Medicare population are limited. **Objective:** To characterize individuals with AATD, describe clinical outcomes/healthcare research utilization (HCRU) among individuals...

Full description

Bibliographic Details
Main Authors: Nikhil Khandelwal, Jimmy Hinson, Trinh Nguyen, Alexjandro Daviano, Yihua Xu, Brandon T. Suehs, Sally Higgins, Marie Sanchirico, J. Michael Wells
Format: Article
Language:English
Published: Columbia Data Analytics, LLC 2025-02-01
Series:Journal of Health Economics and Outcomes Research
Online Access:https://doi.org/10.36469/001c.127446

Internet

https://doi.org/10.36469/001c.127446

Similar Items